The UK's most complete GLP-1 guide
Every Question Answered. Every Side Effect Explained.
- How GLP-1 medications work
- Mounjaro vs Wegovy compared
- Injection instructions
- Side effects & solutions
- What to eat on treatment
- FAQs answered
Free tracker included with every download this week
What Is The Mounjaro Golden Dose?
The "Mounjaro golden dose" is a term used in weight management discussions to describe the optimal effective dose of tirzepatide that balances significant weight loss results with manageable side effects. In the UK, the golden dose is typically considered to be 10 mg once weekly, though individual responses vary considerably. This guide explains what this means within NHS and UK prescribing context, and helps you understand dose titration and eligibility across different UK healthcare pathways.
10,000+ calculations today · NHS-aligned thresholds · 100% free
Calculate Your BMI Instantly
Enter your height and weight below. Supports both imperial (stone & lbs) and metric (kg). Results include NHS category, healthy weight range, and ethnicity adjustments.
What Is BMI and Why Does It Matter?
Body Mass Index (BMI) is the most widely used screening tool for assessing whether your weight falls within a healthy range. Used by the NHS, GPs, and weight management services across the UK, BMI provides a quick snapshot of your weight relative to your height. The formula is simple: your weight in kilograms divided by your height in metres squared (kg/m²).
While BMI isn't a perfect measure — it doesn't account for muscle mass, bone density, or fat distribution — it remains the standard first step in identifying potential weight-related health risks including type 2 diabetes, cardiovascular disease, high blood pressure, and certain cancers.
The NHS also recommends adjusted thresholds for people of South Asian, Chinese, or Black African heritage — a BMI of 23 or above is classified as overweight, and 27.5 as obese. Our calculator includes this adjustment as a one-click toggle.
Understanding Mounjaro Dosing and the Golden Dose Concept
Mounjaro (tirzepatide) is a prescription-only GIP and GLP-1 receptor agonist licensed in the UK for weight management. The medication is available in doses from 2.5 mg up to the maximum of 15 mg, all administered as a once-weekly injection via a KwikPen device.
The term "golden dose" emerged from clinical practice and trial data, not from official NHS or MHRA guidance. The 10 mg dose appears to deliver strong weight loss results for many patients while side effects often become more manageable compared to the initial escalation period. However, it is crucial to understand that this is an average observation, not a assured outcome, and individual responses vary significantly.
In the SURMOUNT-1 clinical trial, the 10 mg dose produced an average weight loss of approximately 19.5% of body weight over 72 weeks when combined with a reduced-calorie diet and increased physical activity. The 15 mg dose showed slightly greater results at 20.9%, whilst the 5 mg dose achieved approximately clinically studied weight loss. Your GP or prescriber will assess which dose is appropriate for you based on your personal health profile.
Clinically BackedWeight Loss
No appointments. No waiting rooms. Just care — from a UK-regulated online pharmacy.
How It Works
Three simple steps to understand your weight and take action.
Enter your height and weight in our free calculator. Get your BMI, NHS category, healthy weight range, and ethnicity-adjusted thresholds instantly.
If your BMI suggests you're overweight or obese, explore our GLP-1 calculators to project potential weight loss on Mounjaro or Wegovy.
Use our progress tracker to log your weight weekly, visualise your journey with charts, and stay motivated — all stored privately in your browser.
Free Weight Loss Tools & Guides
Everything you need to understand your weight, explore medication options, and track your progress — completely free.
Mounjaro Dose Titration and NHS Prescribing Context
Mounjaro dosing follows a set titration schedule: most patients start at 2.5 mg for weeks 1–4, then escalate to 5 mg for weeks 5–8. Further increases to 7.5 mg, 10 mg, 12.5 mg, and 15 mg occur every 4 weeks, depending on tolerability and response. In NHS tier 3 specialist weight management services, prescribers follow NICE-aligned guidance when determining appropriate escalation.
The "golden dose" concept reflects that many patients experience a sweet spot around 10 mg where weight loss is substantial and side effects (nausea, constipation, diarrhoea) are often better tolerated than at higher doses. That said, some patients respond better at 7.5 mg or require the full 15 mg for optimal results. Use our GLP-1 weight loss calculator to estimate potential weight loss at different tirzepatide doses, and discuss the best approach with your prescriber.
- Dual GIP/GLP-1 receptor agonist
- Up to 22.5% body weight loss (SURMOUNT-1)
- Weekly injection, dose escalation over 20+ weeks
- Available via private prescription in the UK
- Doses: 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg
- GLP-1 receptor agonist
- Up to 15–17% body weight loss (STEP trials)
- Weekly injection, 5-step dose escalation
- NHS & private prescription available
- Doses: 0.25mg → 0.5mg → 1mg → 1.7mg → 2.4mg
Mounjaro vs Wegovy: Head-to-Head
A side-by-side comparison of the two most popular GLP-1 weight loss medications available in the UK.
| Feature | Mounjaro | Wegovy |
|---|---|---|
| Drug class | Dual GIP/GLP-1 agonist | GLP-1 agonist |
| Active ingredient | Tirzepatide | Semaglutide |
| Avg. weight loss | 15–22.5% | 12–17% |
| Key trial | SURMOUNT-1 (2022) | STEP 1 (2021) |
| Max dose | 15 mg weekly | 2.4 mg weekly |
| Escalation period | 20–32 weeks | 16–20 weeks |
| Administration | Weekly injection (pen) | Weekly injection (pen) |
| NHS availability | Private prescription only | NHS & private |
| Approx. private cost | £150–£250/month | £150–£300/month |
| Common side effects | Nausea, diarrhoea, constipation | Nausea, vomiting, diarrhoea |
Data sourced from SURMOUNT-1 and STEP 1 clinical trials. Costs are approximate and vary by provider. Always consult a prescriber.
Am I Eligible for Weight Loss Medication?
In the UK, eligibility for GLP-1 weight loss medications like Mounjaro and Wegovy is based on your BMI and overall health profile.
- BMI of 30 or above (obese)
- Age 18 or over
- No contraindicated conditions
- Committed to lifestyle changes
- BMI of 27 or above
- Plus type 2 diabetes
- Or high blood pressure
- Or obstructive sleep apnoea
Use our BMI calculator to check whether your BMI falls within the eligible range.
How We Built These Tools
Every calculator and guide on myweightcheck is built with accuracy and transparency in mind. Our BMI calculator uses the standard WHO formula with NHS-aligned category thresholds. Our GLP-1 projections are modelled on published clinical trial data from SURMOUNT and STEP studies.
All data stays on your device. We don't require sign-ups, and we don't store your health information on any server. Your progress tracker saves data locally in your browser using localStorage, so only you can see it.
We're based in the UK and our tools are designed specifically for UK users — supporting stone & lbs by default, referencing NHS guidelines, using NICE-approved medication data, and linking to GPhC-registered pharmacies.
Frequently Asked Questions
Common questions about BMI, weight loss medications, and our free UK tools.
Is 10 mg the recommended Mounjaro dose for everyone in the UK?
No. The 10 mg dose is not universally recommended — it is simply where many patients find a balance between efficacy and tolerability. Your prescriber will assess your individual health, comorbidities, and response to lower doses to determine the right dose for you. Some patients do well on 7.5 mg, others require 15 mg.
What side effects might I experience at the golden dose?
Common side effects at any dose include nausea, diarrhoea, vomiting, and constipation. At 10 mg, these may be less severe than during the initial escalation phase, but individual experiences vary. Your GP can advise on managing side effects and whether continuing is appropriate for you.
How long does it take to reach the golden dose?
Following standard titration, reaching 10 mg takes approximately 20–24 weeks (5 months), as you increase by one dose level every 4 weeks starting from 2.5 mg. Some patients may pause or adjust the schedule based on tolerability.
Can I access Mounjaro at the golden dose through the NHS in the UK?
Mounjaro is available through NHS tier 3 specialist weight management services, but access varies significantly by region. You would need referral from your GP and assessment by a specialist team. Waiting times can be lengthy. Private prescribing offers faster access but requires payment.
Is the golden dose the same for Mounjaro and Wegovy?
No — Mounjaro and Wegovy are different medications with different dose ranges. Wegovy's maximum is 2.4 mg (much lower than Mounjaro's 15 mg), so direct dose comparisons do not apply. Discuss which medication may be suitable with your prescriber.
Ready to take control of your weight loss journey?
Start with a free BMI check, explore your GLP-1 options, or begin tracking your progress today. No sign-up. No cost. Just results.